Library Subscription: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Published 6 issues per year

ISSN Print: 0743-4863

ISSN Online: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems

Volume 24, Issue 2, 2007, pp. 147-202
DOI: 10.1615/CritRevTherDrugCarrierSyst.v24.i2.20
Get accessGet access

ABSTRACT

Oral colon-specific drug-delivery systems have recently gained importance for delivering a variety of therapeutic agents. The major obstacles to delivering drugs to the colon are the absorption and degradation pathways in the upper gastrointestinal tract. However, a successfully designed colon-targeted system can overcome these obstacles. Targeting drugs to the colon has proven quite valuable in a variety of disorders, and the colon has proven to be a potential site for local as well as systemic administration of drugs. Colon targeting has proven beneficial for local action in a variety of disease conditions, such as inflammatory bowel disease, irritable bowel syndrome, and colonic cancer. Aminosalicylates, corticosteroids, immunosuppressive agents, cationized antioxidant enzymes, genetically engineered bacteria to produce cytokines, nicotine, and other drugs have exhibited significantly enhanced efficacy when delivered to the colon. Targeting drugs to cancer cells through receptors and ligands have opened up new avenues in the treatment of colonic cancer. Colon targeting has also proven useful for systemic action of protein-peptide drugs such as insulin, calcitonin, and met-enkaphalin and even for other nonpeptide drugs such as cardiovascular and antiasthmatic agents. This review also presents various approaches for targeting orally administered dosage forms to the colon. The use of a prodrug approach, bioadhesive polymers, and coating with pH-sensitive and biodegradable polymers has been, to an extent, highly successful in delivering the targeted formulations to the site of action. Biodegrable hydrogels such as amylose, chondroitin sulphate, chitosan, inulin, guar gum, and pectin have also been successfully used to achieve oral colon-targeted delivery.

CITED BY
  1. Hamidi Mehrdad, Ashrafi Hajar, Azadi Amir, Surface Functionalized Hydrogel Nanoparticles, in Biomedical Materials and Diagnostic Devices, 2012. Crossref

  2. Gellerman Gary, Baskin Sophia, Galia Luboshits, Gilad Yosef, Firer Michael A., Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide, Anti-Cancer Drugs, 24, 2, 2013. Crossref

  3. Roeselers Guus, Bouwman Jildau, Venema Koen, Montijn Roy, The human gastrointestinal microbiota—An unexplored frontier for pharmaceutical discovery, Pharmacological Research, 66, 6, 2012. Crossref

  4. Renukuntla Jwala, Vadlapudi Aswani Dutt, Patel Ashaben, Boddu Sai H.S., Mitra Ashim K., Approaches for enhancing oral bioavailability of peptides and proteins, International Journal of Pharmaceutics, 447, 1-2, 2013. Crossref

  5. ADVANCED DRUG DELIVERY, in Biotechnology and Biopharmaceuticals, 2013. Crossref

  6. Patel Mayur Mahendrakumar, Colon targeting: an emerging frontier for oral insulin delivery, Expert Opinion on Drug Delivery, 10, 6, 2013. Crossref

  7. J. McInnes Fiona, N. E. Stevens Howard, IN VIVOIMAGING FOR VALIDATION OF ORAL DOSE PERFORMANCE, in Drug Delivery Applications of Noninvasive Imaging, 2013. Crossref

  8. Patel Mayur M., Amin Avani F., Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome, Carbohydrate Polymers, 86, 2, 2011. Crossref

  9. Patel Mayur M., Amin Avani F., Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease, Pharmaceutical Development and Technology, 18, 2, 2013. Crossref

  10. M Beesh, P Majewska, Th. F. Vandamme, Synthesis and characterization of dextran esters as coating or matrix systems for oral delivery of drugs targeted to the colon., International Journal of Drug Delivery, 2, 1, 2010. Crossref

  11. Karrout Y., Neut C., Wils D., Siepmann F., Deremaux L., Flament M. P., Dubreuil L., Desreumaux P., Siepmann J., Peas starch-based film coatings for site-specific drug delivery to the colon, Journal of Applied Polymer Science, 119, 2, 2011. Crossref

  12. Elgadir M.Abd, Uddin Md.Salim, Ferdosh Sahena, Adam Aishah, Chowdhury Ahmed Jalal Khan, Sarker Md.Zaidul Islam, Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: A review, Journal of Food and Drug Analysis, 23, 4, 2015. Crossref

  13. Dilmi Abdelkader, Bartil Tahar, Yahia Nadjet, Benneghmouche Zinneddine, Hydrogels Based on 2-Hydroxyethylmethacrylate and Chitosan: Preparation, Swelling Behavior, and Drug Delivery, International Journal of Polymeric Materials and Polymeric Biomaterials, 63, 10, 2014. Crossref

  14. Nidhi , Rashid Muzamil, Kaur Veerpal, Hallan Supandeep Singh, Sharma Saurabh, Mishra Neeraj, Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review, Saudi Pharmaceutical Journal, 24, 4, 2016. Crossref

  15. Saphier Sigal, Karton Yishai, Novel salicylazo polymers for colon drug delivery: Dissolving polymers by means of bacterial degradation, Journal of Pharmaceutical Sciences, 99, 2, 2010. Crossref

  16. Patel Mayur M, Getting into the colon: approaches to target colorectal cancer, Expert Opinion on Drug Delivery, 11, 9, 2014. Crossref

  17. Kagan Leonid, Hoffman Amnon, Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations, Expert Opinion on Drug Delivery, 5, 6, 2008. Crossref

  18. Garbacz Grzegorz, Rappen Gerd-Martin, Koziolek Mirko, Weitschies Werner, Dissolution of mesalazine modified release tablets under standard and bio-relevant test conditions, Journal of Pharmacy and Pharmacology, 67, 2, 2015. Crossref

  19. Corá Luciana A., Américo Madileine F., Oliveira Ricardo B., Serra Cristina H. R., Baffa Oswaldo, Evangelista Raul C., Oliveira Giselle F., Miranda José Ricardo Aruda, Biomagnetic Methods: Technologies Applied to Pharmaceutical Research, Pharmaceutical Research, 28, 3, 2011. Crossref

  20. Wang Chunxia, Ho Paul C., Lim Lee Yong, Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells, International Journal of Pharmaceutics, 400, 1-2, 2010. Crossref

  21. Patel Mayur Mahendrakumar, Drug Delivery: Oral Colon-Specific, in Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 2015. Crossref

  22. Patel Mayur M., Amin Avani F., Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer, Drug Delivery, 18, 4, 2011. Crossref

  23. Zhaveh Sara, Mohsenifar Afshin, Beiki Mina, Khalili Seyede Tahereh, Abdollahi Alina, Rahmani-Cherati Tavoos, Tabatabaei Meisam, Encapsulation of Cuminum cyminum essential oils in chitosan-caffeic acid nanogel with enhanced antimicrobial activity against Aspergillus flavus, Industrial Crops and Products, 69, 2015. Crossref

  24. Patel Mayur M, Colon: a gateway for chronotherapeutic drug delivery systems, Expert Opinion on Drug Delivery, 12, 9, 2015. Crossref

  25. Cao Feng, Ren Yong, Hua Weiyi, Cyclomaltoheptaose mixed esters of anti-inflammatory drugs and short-chain fatty acids and study of their enzymatic hydrolysis in vitro, Carbohydrate Research, 344, 4, 2009. Crossref

  26. Singh Shikha, Chauhan Parul, Ravi Makthala, Taneja Isha, Wahajuddin Wahajuddin, Yadav Prem. P., A mild CuBr–NMO oxidative system for the coupling of anilines leading to aromatic azo compounds, RSC Advances, 5, 76, 2015. Crossref

  27. Wu Baojian, Kulkarni Kaustubh, Basu Sumit, Zhang Shuxing, Hu Ming, First-Pass Metabolism via UDP-Glucuronosyltransferase: a Barrier to Oral Bioavailability of Phenolics, Journal of Pharmaceutical Sciences, 100, 9, 2011. Crossref

  28. Khan Imran, Khan Momin, Umar Muhammad Naveed, Oh Deog‐Hwan, Nanobiotechnology and its applications in drug delivery system: a review, IET Nanobiotechnology, 9, 6, 2015. Crossref

  29. Shah Nitesh, Shah Tejal, Amin Avani, Polysaccharides: a targeting strategy for colonic drug delivery, Expert Opinion on Drug Delivery, 8, 6, 2011. Crossref

  30. Zhao Rui, Tan Chunyan, Xie Yonghua, Gao Chunmei, Liu Hongxia, Jiang Yuyang, One step synthesis of azo compounds from nitroaromatics and anilines, Tetrahedron Letters, 52, 29, 2011. Crossref

  31. Wen Hong, Park Kinam, Introduction and Overview of Oral Controlled Release Formulation Design, in Oral Controlled Release Formulation Design and Drug Delivery, 2010. Crossref

  32. Tu Jiasheng, Shen Yan, Mahalingam Ravichandran, Jasti Bhaskara, Li Xiaoling, Polymers in Oral Modified Release Systems, in Oral Controlled Release Formulation Design and Drug Delivery, 2010. Crossref

  33. Hamidi Mehrdad, Azadi Amir, Rafiei Pedram, Hydrogel nanoparticles in drug delivery, Advanced Drug Delivery Reviews, 60, 15, 2008. Crossref

  34. Rostamizadeh Kobra, Moslehi Mohammd, Hamidi Mehrdad, Hydrogel Nanoparticles: Drug Delivery, in Encyclopedia of Biomedical Polymers and Polymeric Biomaterials, 2015. Crossref

  35. Asghar Laila Fatima Ali, Chandran Sajeev, Design and evaluation of matrices of Eudragit with polycarbophil and carbopol for colon-specific delivery, Journal of Drug Targeting, 16, 10, 2008. Crossref

  36. Lin Shan-Yang, Kawashima Yoshiaki, Current status and approaches to developing press-coated chronodelivery drug systems, Journal of Controlled Release, 157, 3, 2012. Crossref

  37. Patel Mayur M., Amin Avani F., Design and Optimization of Colon-Targeted System of Theophylline for Chronotherapy of Nocturnal Asthma, Journal of Pharmaceutical Sciences, 100, 5, 2011. Crossref

  38. Afratis Nikos, Gialeli Chrisostomi, Nikitovic Dragana, Tsegenidis Theodore, Karousou Evgenia, Theocharis Achilleas D., Pavão Mauro S., Tzanakakis George N., Karamanos Nikos K., Glycosaminoglycans: key players in cancer cell biology and treatment, FEBS Journal, 279, 7, 2012. Crossref

  39. Celkan Armağan, Acartürk Füsun, Tuğcu-Demiröz Fatmanur, Gökçora Nahide, Akkaş Burcu Esen, Güner Levent A., Gamma scintigraphic studies on guar gum-based compressed coated tablets for colonic delivery of theophylline in healthy volunteers, Journal of Drug Delivery Science and Technology, 32, 2016. Crossref

  40. Jung Yunjin, Kim Young Mi, What should be considered on design of a colon-specific prodrug?, Expert Opinion on Drug Delivery, 7, 2, 2010. Crossref

  41. Park Shinhee, Cheng Sunny Lihua, Cui Julia Yue, Characterizing drug-metabolizing enzymes and transporters that are bona fide CAR-target genes in mouse intestine, Acta Pharmaceutica Sinica B, 6, 5, 2016. Crossref

  42. Patel Mayur M, Cutting-edge technologies in colon-targeted drug delivery systems, Expert Opinion on Drug Delivery, 8, 10, 2011. Crossref

  43. Date Abhijit A., Hanes Justin, Ensign Laura M., Nanoparticles for oral delivery: Design, evaluation and state-of-the-art, Journal of Controlled Release, 240, 2016. Crossref

  44. Patel Mayur M., Shah Tejal J., Amin Avani F., Shah Nitesh N., Design, Development and Optimization of a Novel Time and pH-Dependent Colon Targeted Drug Delivery System, Pharmaceutical Development and Technology, 14, 1, 2009. Crossref

  45. Niu Zhigao, Conejos-Sánchez Inmaculada, Griffin Brendan T., O’Driscoll Caitriona M., Alonso María J., Lipid-based nanocarriers for oral peptide delivery, Advanced Drug Delivery Reviews, 106, 2016. Crossref

  46. Wong Chun Y., Al-Salami Hani, Dass Crispin R., Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin, International Journal of Pharmaceutics, 537, 1-2, 2018. Crossref

  47. Tang Lirong, Lin Fengcai, Li Tao, Cai Zhenghan, Hong Biyun, Huang Biao, Design and synthesis of functionalized cellulose nanocrystals-based drug conjugates for colon-targeted drug delivery, Cellulose, 25, 8, 2018. Crossref

  48. Sinhmar Gurpreet Kaur, Shah Neel N., Rawal Shruti U., Chokshi Nimitt V., Khatri Hiren N., Patel Bhoomika M., Patel Mayur M., Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease, Artificial Cells, Nanomedicine, and Biotechnology, 46, sup2, 2018. Crossref

  49. Shaban Nadia Z., Yehia Salah A., Shoueir Kamel R., Saleh Samar R., Awad Doaa, Shaban Shaban Y., Design, DNA binding and kinetic studies, antibacterial and cytotoxic activities of stable dithiophenolato titanium(IV)-chitosan Nanocomposite, Journal of Molecular Liquids, 287, 2019. Crossref

  50. Babu R. Jayachandra, Annaji Manjusha, Alsaqr Ahmed, Arnold Robert D., Animal-Based Materials in the Formulation of Nanocarriers for Anticancer Therapeutics, in Polymeric Nanoparticles as a Promising Tool for Anti-cancer Therapeutics, 2019. Crossref

  51. Patil Saurabh, Narvekar Aditya, Puranik Amita, Jain Ratnesh, Dandekar Prajakta, Formulation of Therapeutic Proteins: Strategies for Developing Oral Protein Formulations, in Innovative Dosage Forms, 2019. Crossref

  52. Cheng Hao, Huang Shiyu, Huang Gangliang, Design and application of oral colon administration system, Journal of Enzyme Inhibition and Medicinal Chemistry, 34, 1, 2019. Crossref

  53. Thitinan Sumalee, McConville Jason T., Pulsatile Delivery for Controlling Drug Release, in Controlled Release in Oral Drug Delivery, 2011. Crossref

  54. Cai Xiang, Yang Liqun, Zhang Li-Ming, Wu Qing, Synthesis and anaerobic biodegradation of indomethacin-conjugated cellulose ethers used for colon-specific drug delivery, Bioresource Technology, 100, 18, 2009. Crossref

  55. Khotimchenko M., Pectin polymers for colon-targeted antitumor drug delivery, International Journal of Biological Macromolecules, 158, 2020. Crossref

  56. Drug Delivery: Oral Colon-Specific, in Encyclopedia of Pharmaceutical Science and Technology, Fourth Edition, 2013. Crossref

  57. Zhu Quangang, Chen Zhongjian, Paul Pijush Kumar, Lu Yi, Wu Wei, Qi Jianping, Oral delivery of proteins and peptides: Challenges, status quo and future perspectives, Acta Pharmaceutica Sinica B, 11, 8, 2021. Crossref

  58. Azorín-Ortuño María, Yañéz-Gascón María Josefa, Pallarés Francisco J., Vallejo Fernando, Larrosa Mar, García-Conesa María Teresa, Tomás-Barberán Francisco, Espín Juan Carlos, Pharmacokinetic Study of trans-Resveratrol in Adult Pigs, Journal of Agricultural and Food Chemistry, 58, 20, 2010. Crossref

  59. Williams Martin A. K., Cucheval Aurelie, Nasseri Abrisham Tanhatan, Ralet Marie-Christine, Extracting Intramolecular Sequence Information from Intermolecular Distributions: Highly Nonrandom Methylester Substitution Patterns in Homogalacturonans Generated by Pectinmethylesterase, Biomacromolecules, 11, 6, 2010. Crossref

  60. Saphier Sigal, Haft Avital, Margel Shlomo, Bacterial Reduction as Means for Colonic Drug Delivery: Can Other Chemical Groups Provide an Alternative to the Azo Bond?, Journal of Medicinal Chemistry, 55, 23, 2012. Crossref

  61. Larrosa Mar, Tomé-Carneiro Joao, Yáñez-Gascón María J., Alcántara David, Selma María V., Beltrán David, García-Conesa María T., Urbán Cristina, Lucas Ricardo, Tomás-Barberán Francisco, Morales Juan C., Espín Juan Carlos, Preventive Oral Treatment with Resveratrol Pro-prodrugs Drastically Reduce Colon Inflammation in Rodents, Journal of Medicinal Chemistry, 53, 20, 2010. Crossref

  62. Xu Wenhao, Su Wenjing, Xue Zhencheng, Pu Faxiang, Xie Zhangfu, Jin Kongliang, Polyakov Nikolay E., Dushkin Alexander V., Su Weike, Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method, Pharmaceutical Research, 38, 4, 2021. Crossref

  63. Sivanesan Iyyakkannu, Gopal Judy, Muthu Manikandan, Shin Juhyun, Oh Jae-Wook, Reviewing Chitin/Chitosan Nanofibers and Associated Nanocomposites and Their Attained Medical Milestones, Polymers, 13, 14, 2021. Crossref

  64. Deshmukh Rohitas, Bridging the Gap of Drug Delivery in Colon Cancer: The Role of Chitosan and Pectin Based Nanocarriers System, Current Drug Delivery, 17, 10, 2020. Crossref

  65. Tedla Noah, Ruiz Jose, Mody Vicky, Wang Xinyu, Bhave Vishakha S., Synthesis, Pharmacokinetics, and Toxicity of Nano-Drug Carriers, in Nanocarriers: Drug Delivery System, 2021. Crossref

  66. Sivanesan Iyyakkannu, Gopal Judy, Muthu Manikandan, Shin Juhyun, Mari Selvaraj, Oh Jaewook, Green Synthesized Chitosan/Chitosan Nanoforms/Nanocomposites for Drug Delivery Applications, Polymers, 13, 14, 2021. Crossref

  67. Sonker Muskan, Bajpai Sushant, Khan Mohd Ashhar, Yu Xiaojun, Tiwary Saurabh Kr, Shreyash Nehil, Review of Recent Advances and Their Improvement in the Effectiveness of Hydrogel-Based Targeted Drug Delivery: A Hope for Treating Cancer, ACS Applied Bio Materials, 4, 12, 2021. Crossref

  68. Mehrdadian Maryam, Khazalpour Sadegh, Amani Ameneh, Jamshidi Mahdi, Electrochemical oxidation of 4-ethynylaniline: A green electrochemical protocol for the synthesis of diazine compounds, Electrochimica Acta, 381, 2021. Crossref

  69. Situ Wenbei, Chen Ling, Wang Xueyu, Li Xiaoxi, Resistant Starch Film-Coated Microparticles for an Oral Colon-Specific Polypeptide Delivery System and Its Release Behaviors, Journal of Agricultural and Food Chemistry, 62, 16, 2014. Crossref

  70. Vinchhi Preksha, Patel Mayur M., Triumph against cancer: invading colorectal cancer with nanotechnology, Expert Opinion on Drug Delivery, 18, 9, 2021. Crossref

  71. Cameron Randall G., Luzio Gary A., Vasu Prasanna, Savary Brett J., Williams Martin A. K., Enzymatic Modification of a Model Homogalacturonan with the Thermally Tolerant Pectin Methylesterase from Citrus: 1. Nanostructural Characterization, Enzyme Mode of Action, and Effect of pH, Journal of Agricultural and Food Chemistry, 59, 6, 2011. Crossref

  72. Lee Hanju, Park Sohee, Ju Sanghyun, Kim Soojin, Yoo Jin-Wook, Yoon In-Soo, Min Do Sik, Jung Yunjin, Preparation and Evaluation of Colon-Targeted Prodrugs of the Microbial Metabolite 3-Indolepropionic Acid as an Anticolitic Agent, Molecular Pharmaceutics, 18, 4, 2021. Crossref

  73. Rade Priyanka P., Giram Prabhanjan S., Shitole Ajinkya A., Sharma Neeti, Garnaik Baijayantimala, Physicochemical and in Vitro Antibacterial Evaluation of Metronidazole Loaded Eudragit S-100 Nanofibrous Mats for the Intestinal Drug Delivery, Advanced Fiber Materials, 4, 1, 2022. Crossref

  74. Bie Pingping, Chen Ling, Li Xiaoxi, Li Lin, Characterization of concanavalin A-conjugated resistant starch acetate bioadhesive film for oral colon-targeting microcapsule delivery system, Industrial Crops and Products, 84, 2016. Crossref

  75. Moghadam Ayoub, Kariminia Samira, Mobarakeh Mohammad Salmani, Novel pH-responsive polyvinyl alcohol/Arabic gum /magnesium oxide nanobiocomposite for oral colon targeted drug delivery, Journal of Drug Delivery Science and Technology, 74, 2022. Crossref

  76. Park Sohee, Kang Changyu, Kim Jaejeong, Ju Sanghyun, Yoo Jin-Wook, Yoon In-Soo, Kim Min-Soo, Lee Jaewon, Jung Yunjin, A Colon-Targeted Prodrug of Riluzole Improves Therapeutic Effectiveness and Safety upon Drug Repositioning of Riluzole to an Anti-Colitic Drug, Molecular Pharmaceutics, 2022. Crossref

  77. Morales-Medina Rocío, Drusch Stephan, Acevedo Francisca, Castro-Alvarez Alejandro, Benie Astrid, Poncelet Denis, Dragosavac Marijana M., Defain Tesoriero María Victoria, Löwenstein Patricia, Yonaha Verónica, Iturralde Ramiro, Gauna Peter Regina, de Vos Paul, Structure, controlled release mechanisms and health benefits of pectins as an encapsulation material for bioactive food components, Food & Function, 13, 21, 2022. Crossref

  78. Tuteja Minkal , Nagpal Kalpana, Recent Advances and Prospects for Plant Gum-Based Drug Delivery Systems: A Comprehensive Review , Critical Reviews™ in Therapeutic Drug Carrier Systems, 40, 2, 2023. Crossref

  79. Wang Yuying, Ahmadi Shokouh, Yu Chengxiao, Zhang Laiming, Hu Xinxin, Ye Xingqian, Chen Shiguo, A rapid method for extraction, purification and structure analysis of chondroitin sulfate from six marine tissues, Food Quality and Safety, 6, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain